51.94
+0.85%
Close of 9 Nov 2026, in USD
Search any instrument
Reference data, closing prices and charts across 45,000 companies, plus crypto, commodities and currencies.
About Conmed
From its filings with the US Securities and Exchange Commission
Conmed is based in Largo, Florida and is incorporated in Delaware. Its shares trade on NYSE under the ticker CNMD. The SEC classifies its business as electromedical & electrotherapeutic apparatus. In the fiscal year to 31 December 2025, it reported revenue of $1.37bn and net income of $47.1m. At that date it held total assets of $2.33bn and shareholders' equity of $1.03bn. By business, General Surgery brought in 58.2% of revenue, followed by Orthopedic Surgery at 41.8%. By region, United States accounted for 56.3%, followed by EMEA at 19.3% and Asia Pacific at 15.2%.
If third-party payors decline to reimburse our customers for our products or reduce reimbursement levels, the demand for our products may decline and our ability to sell our products profitably may be harmed.
We sell our products and services to hospitals, surgical centers, doctors and other healthcare providers, which receive reimbursement for the healthcare services provided to their patients from third-party payors, such as domestic and international government programs, private insurance plans and managed care programs. These third-party payors may deny reimbursement if they determine that a product or service used in a procedure was not in accordance with cost-effective treatment methods, as determined by the third-party payor, or was used for an unapproved indication. Third-party payors may also decline to reimburse for experimental procedures and products. In addition, third-party payors are increasingly attempting to contain healthcare costs by limiting both coverage and the level of reimbursement for medical products and services. If third-party payors deny or decline reimbursement, reduce reimbursement levels or change reimbursement models for our products, demand for our products may decline, or we may experience increased pressure to reduce the prices of our products, which could have a material adverse effect on our sales and results of operations.
Quoted from its 10-K, filed 17 Feb 2026. Read the filing on SEC.gov ↗
Company facts
- Sector
- Health Care
- Industry
- Health Care Equipment & Supplies
- Listed since
- 14 Apr 2020
- Employees
- 3,900
- Head office
- 11311 CONCEPT BOULEVARD, LARGO, FL, 33773
- Incorporated in
- DE
- Classification
- Electromedical & Electrotherapeutic Apparatus
- Filer status
- Large accelerated filer
Leadership
Pay as last reported
- Ms. Laverne CouncilIndependent Chairman of the Board$276,822
- Mr. Patrick BeyerPresident, Chief Executive Officer, Director, since 2014$4.3m
- Mr. Todd GarnerChief Financial Officer, Executive Vice President - Finance$4.6m
- Ms. Hollie FoustExecutive Vice President, General Counsel and Corporate Secretary
- Mr. John FerrellExecutive Vice President, Human Resources
- Mr. Brent LalomiaExecutive Vice President, Regulatory Affairs, Quality Assurance, Clinical Affairs, and Commercial Operations$1.4m
- Mr. Peter ShagoryExecutive Vice President - Strategy and Corporate Development$1.4m
- Mr. Richard GlazeChief Information Officer
- Mr. Stephan EpinetteVice President and General Manager, International
- Mr. Andrew MollerVice President, Corporate Controller
- Ms. Johonna PelletierTreasurer and Vice President - Tax
- Mr. Edward CliffordVice President - Global Manufacturing
Environmental, social and governance
Scores out of 100, from our data supplier
- Overall
- 58
- Environment
- 32
- Social
- 96
- Governance
- 45
- Women in the workforce
- 53%
- Carbon reduction policy
- No
- Human rights policy
- Yes
SWOT analysis
AI-generated by our data supplier. Not written or checked by our editors.
Strengths
- Established Reputation: Conmed Corp has built a strong reputation in the medical device industry over the years.
- Diversified Product Portfolio: The company offers a wide range of products, including surgical equipment and patient monitoring systems, which reduces its dependence on specific product lines.
- Global Presence: Conmed has a global footprint, serving customers in various regions, which increases its market reach and potential for growth.
Weaknesses
- Intense Competition: The medical device industry is highly competitive, and Conmed faces competition from both established players and new market entrants.
- Reliance on Key Suppliers: The company may face supply chain disruptions or price fluctuations due to its reliance on certain key suppliers.
- Regulatory Challenges: Complying with regulations and obtaining necessary approvals for new products can be time-consuming and costly for Conmed.
Opportunities
- Advancements in Medical Technology: The ongoing advancements in medical technology create opportunities for Conmed to develop innovative products and solutions.
- Growing Aging Population: The increasing global elderly population creates a higher demand for medical devices, providing Conmed with growth opportunities.
- Emerging Markets: Expanding into emerging markets, such as Asia and Latin America, can help Conmed tap into new customer segments and drive revenue growth.
Threats
- Economic Volatility: Fluctuations in global economic conditions can impact healthcare spending, which may affect demand for Conmed's products.
- Stringent Regulatory Environment: Stricter regulations and complex compliance requirements in the medical device industry can pose challenges and increase costs for Conmed.
- Technological Disruptions: Rapid technological advancements may render certain products or technologies obsolete, requiring Conmed to constantly innovate and stay ahead.
Sources and methodology
- Data on this tab
- Our data supplier
- Chart on the Overview
- TradingView
Nothing here is investment advice. Prices can be delayed or wrong, so check with the exchange before relying on them. Data for this page. How we cover markets.